New York, NY – June 19, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) are pleased to announce an alliance between Transcatheter Cardiovascular Therapeutics (TCT) and the VEITHsymposium. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. VEITHsymposium is the leading global conference covering all aspects of vascular medicine, vascular surgery and endovascular intervention.
As part of this alliance, the two organizations will closely collaborate on creating educational content for physicians, surgeons and other healthcare professionals. The VEITHsymposium leadership will be actively involved in developing the endovascular program for TCT 2019, taking place September 25-29 in San Francisco, California. The VEITHsymposium group will also plan dedicated critical limb ischemia and aortic sessions at TCT 2019. Similarly, CRF will actively participate in the development of a two-day hands-on training pavilion and other interventional sessions at this year’s VEITHsymposium, which will take place November 19-23 in New York City.
“We are pleased to be partnering with such an esteemed educational conference as the VEITHsymposium,” said Juan F. Granada, MD, President and Chief Executive Officer of CRF. “Over the last 45 years, they have had a remarkable influence on medical education and innovation in the field which has had a tremendous impact on patient care.”
“This alliance between 2 leading continuing medical educational meetings has as its goal the provision of the best, most up-to-date information possible to all those specializing in the care of non-cardiac vascular disease patients,” said Frank J. Veith, Chairman of VEITHsymposium. “This unique alliance will lead to better, more appropriate care for the increasing number of vascular disease patients around the world, while recognizing the reality that many specialties are involved in providing this care.”
“Vascular disease is a leading cause of death and disability,” said Sahil A. Parikh, MD, Director, Endovascular Services at the Center for Interventional Vascular Therapy at New York-Presbyterian/ Columbia University Irving Medical Center and Director of the Endovascular Program of TCT. “It’s critically important for physicians and other healthcare professionals to be educated and trained on the latest endovascular treatments. This alliance will help improve the survival and quality of life for patients with vascular disease by emphasizing multidisciplinary care of vascular patients.”
"Limitless opportunities for improved care of vascular patients is the primary goal of this new and exciting alliance between two well established giants in the area of education,” said Enrico Ascher, MD, Co-Chairman of VEITHsymposium. “Providing a balanced, progressive environment where all vascular care professionals can learn from each other is one other motivating factor that led to this arrangement. I’m certain that this new concept of working together for the benefit of our patients and for the advancement of science will succeed big time!”
VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. VEITHsymposium is sponsored and CME accredited by the Cleveland Clinic.
VEITHsymposium, now in its 46th year, was the first vascular surgery organization to bring together at one site radiologists, cardiologists, cardiac surgeons and vascular medicine specialists with vascular surgeons to exchange information and scientific innovations in a collegial environment. This allows members of each specialty to profit from learning the unique skills and approaches of other specialties, thereby improving their ability to care for vascular patients.
VEITHsymposium recognizes the importance and contributions of other specialties to the care of vascular diseases and intends to make the meeting more multi-specialty than it already is (25% of speakers are currently from specialties other than vascular surgery). To that end, VEITHsymposium will add more experts in other specialties (interventional cardiology, interventional radiology and vascular medicine) to its leadership team and increase their involvement in program development. The goal is to attract more non-vascular surgeon attendees since the quality of the program contains so much information that these other specialties must know, but which may not be available at their specialty meetings.
About CRF, TCT, and TCTMD
The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For nearly 30 years, CRF has helped pioneer innovations in interventional cardiology and educated doctors on the latest treatments for heart disease.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 31st year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field. TCT also includes interactive training where clinicians can gain vital skills to apply immediately to their practices.
TCTMD is the most comprehensive online resource in interventional cardiology and provides in-depth coverage of the percutaneous treatment of cardiovascular disease.
For more information about TCT/CRF, visit www.crf.org, www.tctconference.com, and www.tctmd.com.
For more information about VEITHsymposium, visit www.veithsymposium.org.